These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 4764833)
41. [Consequences of global respiratory insufficiency]. Rossier PH Munch Med Wochenschr; 1966 Jun; 108(25):1340-2. PubMed ID: 6014395 [No Abstract] [Full Text] [Related]
42. [Bronchodilating drugs]. Vale JR Tidsskr Nor Laegeforen; 1973 Nov; 93(33):2408-9. PubMed ID: 4776307 [No Abstract] [Full Text] [Related]
43. [The bronchodilating effect of ephedrine tablets in bronchial asthma]. Faurschou M; Svendsen UG Ugeskr Laeger; 1993 Nov; 155(46):3784-5. PubMed ID: 8256378 [No Abstract] [Full Text] [Related]
44. [Current possibilities of the treatment of chronic obstructive pulmonary disease: bronchodilating medication of long duration]. Stepanian IE Ter Arkh; 2005; 77(3):82-7. PubMed ID: 15881110 [No Abstract] [Full Text] [Related]
45. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma]. Kokubu H Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230 [TBL] [Abstract][Full Text] [Related]
51. [Comparison of bronchodilating and metabolic effects of intravenous aminophylline and subcutaneous epinephrine individually and in combination in patients with bronchial asthma]. Kihara N; Makino S Arerugi; 1982; 31(7):390-400. PubMed ID: 6295342 [No Abstract] [Full Text] [Related]
52. [Bronchodilating effect of inhalation of aerosolized aminophylline in asthmatic patients]. Kokubu H Arerugi; 1995 Dec; 44(12):1379-86. PubMed ID: 8871292 [TBL] [Abstract][Full Text] [Related]
53. [Clinical manifestations and specific features of the course of adenogenic tuberculosis in adults]. Ozerova LV; Zaĭtseva IP; Chistiakova NA Probl Tuberk; 2003; (3):42-5. PubMed ID: 12744064 [TBL] [Abstract][Full Text] [Related]
54. [Comparative study of bronchodilating effects and action on the cardiovascular system of 2 sympathomimetic agents: berotec and alupent]. Zieliński J; Chodosowska E; Koziorowski A Gruzlica; 1973 Dec; 41(12):1249-58. PubMed ID: 4774750 [No Abstract] [Full Text] [Related]
55. [Treatment of asthmatic dyspnea with a new bronchodilating substance]. Günthner W Ther Umsch; 1965 Aug; 22(8):418-20. PubMed ID: 5842759 [No Abstract] [Full Text] [Related]
56. [Bronchodilating inhalation anesthetics in bronchial asthma and status asthmaticus]. Pedersen CM; Stjernholm PH; Hansen TG; Lybecker H Ugeskr Laeger; 1994 Jan; 156(1):25-30. PubMed ID: 8291152 [TBL] [Abstract][Full Text] [Related]
58. Bronchodilating drugs and airway reactivity. Guerrin F; Robin H; Lahoutte C; Voisin C Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561 [TBL] [Abstract][Full Text] [Related]
59. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood]. Nachtigall C Med Monatsschr; 1968 Dec; 22(12):555-7. PubMed ID: 5709425 [No Abstract] [Full Text] [Related]
60. Current best practice for nebuliser treatment. The Nebulizer Project Group of the British Thoracic Society Standards of Care Committee. Thorax; 1997 Apr; 52 Suppl 2():S1-3. PubMed ID: 9155846 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]